Please login to the form below

Not currently logged in
Email:
Password:

Immodulon

This page shows the latest Immodulon news and features for those working in and with pharma, biotech and healthcare.

Latest appointments

  • Immodulon Therapeutics bolsters senior team Immodulon Therapeutics bolsters senior team

    Independent biopharmaceutical company Immodulon Therapeutics has appointed Dr Jerome Zeldis as its executive vice chairman. ... the continued clinical development and commercialisation of Immodulon’s lead immunotherapy compound IMM-101”.

  • Immodulon Therapeutics appointments two new board of directors Immodulon Therapeutics appointments two new board of directors

    Immodulon Therapeutics appointments two new board of directors. Anthony Bolton and Sir Simon Robertson join the biopharma firm. ... Immodulon Therapeutics, a privately held, late-stage biopharmaceutical company focused on immuno-oncology has made two new

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics